In vitro screening for chemokine antagonists

Area of Science:

• Immunology
• Pharmacology
• Drug Discovery

Background:

• Chemokines are crucial for immune cell migration and host defense.
• Chemokine receptors, a type of G-protein-coupled receptor, are targets for inflammatory disease therapeutics.
• Significant pharmaceutical investment is directed towards chemokine-based drug discovery.

Purpose of the Study:

• To review in vitro assays used in identifying chemokine receptor antagonists.
• To provide historical context of assay development in chemokine drug discovery.
• To discuss clinical successes and failures of chemokine-targeted therapies.

Main Methods:

• Literature review of in vitro assays for chemokine receptor antagonist screening.
• Analysis of historical trends in drug discovery assays.
• Examination of clinical trial outcomes for chemokine-targeting drugs.

Main Results:

• Overview of various in vitro assay types employed at different discovery stages.
• Examples illustrating the progression of drug candidates through the discovery pipeline.
• Discussion of challenges and reasons for clinical trial failures.

Conclusions:

• Targeting chemokine receptors remains a viable strategy despite past setbacks.
• Future screening approaches may incorporate chemokine receptor dimerization.
• Continued research is needed to overcome challenges in developing effective chemokine-based therapeutics.